HFE genotyping using multiplex allele-specific polymerase chain reaction and capillary electrophoresis

Hereditary hemochromatosis is recognized as one of the most common autosomal recessive disorders, with a prevalence of 1 in 200 to 400 in the white population. Early detection and treatment are completely effective in preventing pathology. It is anticipated that testing for hereditary hemochromatosi...

Full description

Saved in:
Bibliographic Details
Published inArchives of pathology & laboratory medicine (1976) Vol. 123; no. 12; pp. 1177 - 1181
Main Authors Lubin, I M, Yamada, N A, Stansel, R M, Pace, R G, Rohlfs, E M, Silverman, L M
Format Journal Article
LanguageEnglish
Published United States College of American Pathologists 01.12.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Hereditary hemochromatosis is recognized as one of the most common autosomal recessive disorders, with a prevalence of 1 in 200 to 400 in the white population. Early detection and treatment are completely effective in preventing pathology. It is anticipated that testing for hereditary hemochromatosis will increase, as will the need for a technology that can handle the demand. To describe a high-throughput, single-tube, allele-specific multiplex polymerase chain reaction assay for identifying the 2 mutations in the HFE gene associated with hereditary hemochromatosis. Fluorescence-labeled polymerase chain reaction products from a multiplex polymerase chain reaction are analyzed by automated capillary electrophoresis. The assay was validated by analysis of 25 blinded samples, and results were concordant with an established laboratory assay. The assay described offers a significant improvement over manual laboratory assays in throughput, reduced technologist time, and cost.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0003-9985
1543-2165
DOI:10.5858/1999-123-1177-HGUMAS